Market Introduction
Microfluidics involves processing or manipulation of small amount of fluidics. It studies various systems that can process small quantities of fluids by using tiny channels having dimensions in micrometers. Microfluidics is an emerging technology having a wide range of applications in biology, chemistry, optics and information technology. This technology is widely used for various processes such as capillary electrophoresis, sample injection in mass spectrometry, immunoassays, flow cytometry, DNA analysis, separation and manipulation of cells, PCR amplification, among others. Additionally, microfluidics is also used in the diagnosis of diseases such as cancer and research.
Market Overview and Dynamics
The North America Microfluidics market is expected to reach US$ 18,301.24 million in 2027 from US$ 4,901.47 million in 2019. The market is anticipated to grow with a CAGR of 18.2% from 2020 to 2027. Factors driving the market growth include growing market for microfluidics technologies in point-of-care testing, and technological advancement in microfluidics products. However, challenges in product commercialization is the major factor hindering the market growth. COVID19 has affected the North American countries which has led to high number of coronavirus cases. Coronavirus diagnostic with microfluidics is one option that’s gained a lot of attention
Key Market Segments
In terms of product, the device segment held the largest share of the market in 2019; however, the microfluidic chips segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of material, the PDMS segment held a larger share of the market in 2019 and similar segment is estimated to register a higher market share in the market during the forecast period. Likewise, in terms of application, the in vitro diagnostics segment held a larger share of the market in 2019 and is estimated to register a higher CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), World Heart Federation, National Center for Biotechnology Information are some of the major primary and secondary sources for the North America Microfluidics market included in the report.
Reasons to buy the report
- To understand the North America Microfluidics market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the North America Microfluidics market
- Efficiently plan M&A and partnership deals in the North America Microfluidics market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form the North America Microfluidics market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in the region
North America Microfluidics Market Segmentation
Microfluidics Market – By Product
- Devices
- Microfluidic Chips
- Microfluidic Sensors
- Micropumps
- Microneedles
- Other Products
Microfluidics Market – By Material
- PDMS
- Glass
- Silicon
- Polymer
- Other Materials
Microfluidics Market – By Application
- In Vitro Diagnostics
- Point-of-Care Testing
- Clinical Diagnostics
- Pharmaceutical and Life Science Research
- Drug Discovery
- Other Applications
Company Profiles
- Agilent Technologies, Inc.,
- BD
- Bio-Rad Laboratories Inc.
North America Microfluidics Market Strategic Insights
North America Microfluidics Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 4,901.47 Million |
| Market Size by 2027 | US$ 18,301.24 Million |
| CAGR (2020 - 2027) | 18.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Microfluidics Market Country and Regional Insights
